Australian Prescriber

Australian Prescriber Australian Prescriber is an independent peer-reviewed journal and podcast providing critical commentary on drugs and therapeutics for health professionals.

07/09/2026

πŸͺž Acne is not simply a teenage condition that will automatically get better, for many people, it is chronic.
Jo Cheah speaks with dermatologist Belinda Welsh about the chronic inflammatory nature of acne, its substantial psychosocial burden, and the importance of effective treatment to reduce the risk of permanent scarring. Tap to listen: https://bit.ly/4cojgCs

24/08/2026

🦷 When should antibiotic prophylaxis be considered for dental procedures?
Dhineli Perera speaks with dentist Smitha Sukumar about the updated recommendations in Therapeutic Guidelines: Oral and Dental, including when prophylaxis is indicated and important considerations for immunocompromised patients. Listen nowπŸ‘‰ https://bit.ly/4wBgsJo

Read the full article in the August issue πŸ‘‰ https://bit.ly/45Folm6

🚨Did you know the approach to   treatment has changed? Combination topical therapy is recommended as initial and mainten...
19/08/2026

🚨Did you know the approach to treatment has changed? Combination topical therapy is recommended as initial and maintenance treatment for most patients. If oral or topical antibiotics are used, they should be time-limited and paired with a non-antibiotic therapy. πŸ’ŠThe combined oral contraceptive and spironolactone are effective options for women with persistent acne. Oral isotretinoin is the most effective option for severe, scarring or treatment-resistant acne. Read about the latest recommendations in this new article: https://bit.ly/4xEH4dm

Updated clinical guidelines for prevention and management of   and rheumatic   were released in 2025. Get the overview o...
16/08/2026

Updated clinical guidelines for prevention and management of and rheumatic were released in 2025. Get the overview of the guidelines including major changes such as expanded oral options for treatment of Strep A infections in those at high risk of rheumatic fever.πŸ‘‰ https://bit.ly/4xfU1tW

12/08/2026

πŸ”Ž How should acute COVID-19 be managed in the community, and who stands to benefit most from antiviral treatment? Dhineli Perera speaks with infectious diseases physician Josh Davis about the key risk factors for severe disease, the current evidence for oral antivirals, and which patients are most likely to benefit from treatment. Listen now➑️ https://bit.ly/4wUEEHL

There has been a resurgence of   in recent years, including sexually transmitted and congenital syphilis. Prevalence can...
10/08/2026

There has been a resurgence of in recent years, including sexually transmitted and congenital syphilis. Prevalence can be reduced by increasing testing, effective treatment and contact tracing. Testing is recommended in all STI checks and antenatal screening, and for people at increased risk, including high prevalence groups. Learn more: πŸ‘‰ https://bit.ly/4h9Zca5

πŸ“– NEW: Learn about the latest recommendations for assessment and treatment of acute COVID-19 in the community. πŸ‘‰ https:/...
04/08/2026

πŸ“– NEW: Learn about the latest recommendations for assessment and treatment of acute COVID-19 in the community. πŸ‘‰ https://bit.ly/4yUCsBp

The August issue of Australian Prescriber is now live!  It features clinical updates on community treatment of acute COV...
03/08/2026

The August issue of Australian Prescriber is now live!
It features clinical updates on community treatment of acute COVID-19, syphilis testing and treatment, rheumatic fever and rheumatic heart disease, acne vulgaris, and antibiotic prophylaxis for dental procedures.

Read the latest issue here: https://bit.ly/4xkA31l

πŸ“’ Supporting pharmacists' lifelong learningAustralian Prescriber is proud to partner with the Pharmaceutical Society of ...
30/07/2026

πŸ“’ Supporting pharmacists' lifelong learning

Australian Prescriber is proud to partner with the Pharmaceutical Society of Australia to help pharmacists across Australia stay current with independent, evidence-based and accredited continuing professional development (CPD).

This partnership brings together two trusted organisations and some fantastic peer-reviewed clinical content that supports CPD opportunities for pharmacists to maintain confidence, strengthen their knowledge and deliver best-practice patient care.

Together, we're making it easier for pharmacists to access high-quality learning that fits into their professional development journey! Learn more: https://bit.ly/4yLfrk6

Therapeutic Guidelines

Address

133 Abbotsford Street, North
Melbourne, VIC
3051

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+611800061260

Alerts

Be the first to know and let us send you an email when Australian Prescriber posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Australian Prescriber:

Shortcuts

Share

Category